Enhancing Effectiveness of drugs Against Prostate Cancer by Angela Mohan on April 21, 2021 at 5:04 PM
Advanced Functional Materials.
Researchers also investigated whether this system helps more drugs across the vessel wall and deeply into the tumor tissue.
Although nucleotide drugs offer advantages in treating tumors and other diseases, they often suffer from a poor efficiency of crossing the blood vessels and entering the tumor tissue, where their targets reside. This problem greatly limits their clinical applicability and efficacy. Our system demonstrates a good ability to deliver more ASOs into both primary tumor tissue and bone metastases which is the primary site for prostate cancer metastasis, said Pang, an assistant professor in the College of Pharmacy and a member of the Masonic Cancer Center.